GYN
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CARACO Trial - Omission of Lymphadenectomy in Advanced Epithelial Ovarian Cancer Treated With Primary or Interval Cytoreductive Surgery After Neoadjuvant Chemo"
FEATURING
Jean-Marc Classe
- 149 views
- July 10, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Gynecologic Oncology Updates"
FEATURING
Ritu Salani
- 1,691 views
- July 1, 2024
- 13
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endometrial and Ovarian Cancers"
FEATURING
Amer Karam
- 442 views
- June 26, 2024
- 6
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Unveiling the Unique Identity of Clear-Cell Endometrial Cancer - A Comprehensive Comparative Analysis With Ovarian Counterpart and Other Endometrial Subtypes"
FEATURING
Felix Blanc-Durand
- 141 views
- June 11, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Gynecological Cancers Highlights"
FEATURING
Mansoor Raza Mirza
- 1,027 views
- June 18, 2024
- 5
ecancer
ASCO® 2024 Insights: "CARACO Trial - Omission of Lymphadenectomy in Advanced Epithelial Ovarian Cancer"
FEATURING
Jean-Marc Classe
- 139 views
- June 21, 2024
- 1
ecancer
ASCO® 2024 Insights: "BrUOG 354 Trial - Nivo Alone or in Combination With Ipi for People With Ovarian and Other Extra-Renal CCCs Who Had Relapsed After Prior Therapy"
FEATURING
Don Dizon
- 105 views
- June 21, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "BrUOG 354 Trial Final Results - Nivo vs. Nivo/Ipi for Ovarian & Other Extra-Renal Clear Cell Carcinomas"
FEATURING
Don Dizon
- 203 views
- June 13, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ALARICE Study - Avelumab With Axitinib in Persistent/Recurrent Cervical Cancer After Platinum-Based Chemo"
FEATURING
Ka Yu Tse
- 59 views
- June 6, 2024